329 The clinically applied PARP inhibitor talazoparib ameliorates the imiquimod-induced psoriasis in mice

Autor: Molnár, P., Türk-Mázló, A., Polgar, Z., Pór, Á., Kovács, I., Szegedi, A., Szöllösi, A.G., Szántó, M.
Zdroj: Journal of Investigative Dermatology; December 2024, Vol. 144 Issue: 12, Number 12 Supplement 1 pS285-S285, 1p
Databáze: Supplemental Index